Tetanus Neonatorum (Neonatal Tetanus)

Tetanus neonatorum, also known as neonatal tetanus, is an acute, life-threatening, non-communicable bacterial disease caused by Clostridium tetani. It is characterized by generalized muscle rigidity, painful spasms, and autonomic instability. The condition manifests between 3 and 28 days of life, with the majority of cases appearing between days 6 and 8 (mean incubation period: 7 days). It results from infection of the umbilical stump, leading to systemic absorption of tetanospasmin toxin.

Causative Organism

• Clostridium tetani
  
  • Gram-positive, anaerobic, spore-forming rod
  • Produces two toxins:
    
    • Tetanospasmin (neurotoxin): Responsible for clinical disease
    • Tetanolysin (hemolysin): Minor role, damages local tissue
  • Spores are highly resistant to heat, desiccation, and disinfectants
  • Found in soil, dust, animal feces, and rusty objects

Pathophysiology

1. Entry: Spores enter through the umbilical stump during unhygienic cord cutting or application of contaminated substances (e.g., dung, ash, ghee, herbal pastes).
2. Germination: In anaerobic, necrotic tissue (devitalized cord), spores germinate into vegetative bacteria.
3. Toxin Production: Tetanospasmin is released → travels retrogradely along motor neurons to the spinal cord and brainstem.
4. Mechanism of Action:
   
   • Binds irreversibly to presynaptic terminals of inhibitory interneurons
   • Blocks release of glycine and GABA
   • Results in disinhibition of motor neurons → uncontrolled muscle contraction
   • Affects autonomic nervous system → labile blood pressure, tachycardia
5. No Immunity: No person-to-person transmission; no herd immunity

Epidemiology

• Global Burden:
  
  • WHO estimates ~25,000 neonatal deaths annually (2020)
  • Eliminated in >100 countries; persists in low-resource settings
• High-Risk Areas: Rural, poor sanitation, low TT coverage
• Elimination Goal: <1 case per 1,000 live births per district (WHO)

Risk Factors

• Maternal Factors
  
  • No or incomplete tetanus toxoid (TT) vaccination
  • Home delivery without trained birth attendant
  • Previous child with neonatal tetanus
• Delivery & Cord Care
  
  • Unsterile cord cutting instruments (bamboo, knife, sickle)
  • Application of traditional substances (cow dung, soil, turmeric, oil)
  • Delayed cord separation
• Socioeconomic
  
  • Poverty, illiteracy, cultural practices
  • Lack of access to clean delivery kits

Clinical Stages and Presentation

Diagnosis

• Primarily Clinical
  
  • History of unhygienic cord care + onset of spasms in first 2 weeks
  • Spatula Test: Touch posterior pharynx with spatula → jaw clenches (positive in tetanus) vs. gag reflex (normal)
• No Laboratory Confirmation
  
  • Toxin not detectable in serum or CSF
  • Wound culture rarely positive
• Differential Diagnosis
  
  • Hypocalcemic tetany
  • Meningitis/encephalitis
  • Strychnine poisoning
  • Drug withdrawal (opioids)
  • Seizure disorder

Management Workflow

1. Immediate Actions (First Hour)

• Isolate in quiet, dark, draft-free room
• Minimize stimulation (no unnecessary touch, dim lights, silence)
• Airway protection: Suction, position on side
• IV access (avoid IM injections during spasms)
• Oxygen if cyanosed
• Nasogastric tube (for feeding and drug administration)

2. Neutralize Circulating Toxin

• Human Tetanus Immunoglobulin (HTIG)
  
  • Dose: 3,000–6,000 IU IM (single dose)
  • Inject 500 IU around umbilical wound, rest in contralateral thigh
  • Equine TIG (if HTIG unavailable): 10,000–20,000 IU (risk of anaphylaxis → test dose)

3. Eradicate Source of Infection

• Wound Care
  
  • Clean umbilical stump with chlorhexidine 7.1% or hydrogen peroxide
  • Debride necrotic tissue if present
  • Leave open to air
• Antibiotics
  
  • Metronidazole IV (first choice):
    
    • 7.5 mg/kg/dose every 6–8 hours × 10–14 days
  • Penicillin G IV:
    
    • 100,000 IU/kg/day in 4 divided doses × 10–14 days
  • Avoid aminoglycosides (no anaerobic coverage)

4. Control Muscle Spasms

• Benzodiazepines
  
  • Diazepam IV: 0.1–0.3 mg/kg slowly every 3–6 hours
  • Midazolam infusion (if frequent spasms): 0.1–0.3 mg/kg/hr
• Magnesium Sulfate (second-line, with monitoring)
  
  • Loading: 0.2 mmol/kg IV over 30 min
  • Maintenance: 0.08–0.1 mmol/kg/hr
  • Monitor patellar reflex, serum Mg²⁺
• Severe/Refractory Cases
  
  • Muscle relaxants: Vecuronium or Pancuronium
  • Mechanical ventilation in ICU
  • Intrathecal baclofen (rarely used)

5. Supportive Care

• Nutrition
  
  • NGT feeding: Expressed breast milk (EBM)
  • Start 10–20 ml/kg/feed every 2–3 hours
  • TPN if prolonged intubation
• Hydration
  
  • IV fluids: D5½NS or D10½NS
  • Avoid overhydration (risk of SIADH)
• Autonomic Instability
  
  • Labetalol or Morphine for tachycardia/hypertension
  • Atropine for bradycardia
• Fever Control
  
  • Tepid sponging, paracetamol (avoid aspirin)

6. Monitoring

• Continuous cardiorespiratory monitor
• Hourly BP, HR, SpO₂ initially
• Daily weight, input/output
• Watch for laryngospasm, apnea

Prognosis

• With Intensive Care: Mortality 10–20%
• Without Treatment: Mortality >80%
• Poor Prognostic Signs
  
  • Incubation <5 days
  • Onset of spasms <48 hrs after first symptom
  • Spasms within 24 hrs of admission
  • Temperature >40°C
• Survivors: Usually full neurological recovery if treated early

Prevention Strategies

1. Maternal Immunization

• Tetanus Toxoid (TT) Schedule
  
  • TT1: First contact in pregnancy
  • TT2: 4 weeks after TT1
  • TT3: 6 months after TT2
  • TT4 & TT5: Annual boosters (5 doses = lifelong protection)
• Protection:
  
  • 2 doses → 80–90% infant protection
  • 3+ doses → >95% protection

2. Clean Delivery Practices

• Six Cleans (WHO):
  
  1. Clean hands
  2. Clean perineum
  3. Clean surface
  4. Clean cord cutting tool
  5. Clean cord tie
  6. Clean cloth for drying
• Use sterilized blade/scissors
• Chlorhexidine 7.1% for cord cleansing (reduces infection by 50%)

3. Clean Cord Care

• Dry cord care (WHO recommendation in low-risk settings)
• Chlorhexidine in high-risk areas
• Avoid dung, ash, oil, herbs, mud

4. Health Education

• Train traditional birth attendants (TBAs)
• Community awareness on dangers of harmful practices
• Promote facility delivery

5. Surveillance & Response

• Report all cases to district health office
• Investigate delivery practices
• Offer TT to unimmunized mothers in community

WHO Classification of Neonatal Tetanus

Key Nursing Responsibilities

• Handle infant gently to avoid triggering spasms
• Administer medications via NGT if IV not possible
• Record spasm frequency, duration, triggers
• Educate mother on TT vaccination for future pregnancies
• Ensure follow-up immunization (DPT at 6, 10, 14 weeks)

Critical Note: Neonatal tetanus is 100% preventable with maternal TT vaccination and clean delivery/cord care. Every case represents a failure of the health system.